S100A9 and myelodysplastic syndrome: Investigating circulating S100A8, S100A9, and S100A8/A9 in patients’ plasma revealed an elevated level of S100A8 in MDS, but not in AA patients at the time of diagnosis, making it a differential diagnosis marker for these two diseases [44].